New Targets Sample Clauses

New Targets. 8 2.3 [ * ].................................................... 8 2.4 [ * ].................................................... 8 2.5 Exclusivity/Third Party Agreements....................... 9 2.5.1 Exclusivity.............................................. 9 2.5.2 Activities Relating to the Field......................... 9 2.5.3 Joint Decision-Making Process............................ 9 2.5.4 Re-Presentation to Officers.............................. 10 2.5.5 Outside Activities....................................... 10 3.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
New Targets. If a Target is discovered as part of the Research Collaboration, the Party discovering such new Target shall notify the Research Management Committee. At the next Research Management Committee meeting, the parties shall discuss such new Target. If the Research Management Committee decides that the new Target should be included in the Research Collaboration, then Roche Bioscience shall disclose whether the Target is under investigation by another Roche research site. If the new Target is not under investigation by Roche at such time, such new Target shall be included in the Research Collaboration. If the new Target is under investigation by Roche at such time, Roche Bioscience shall notify Tularik in writing within sixty (60) days of such Research Management Committee meeting whether Roche Bioscience shall (a) exclude such Target from the Research Collaboration and the definition of "Target" or (b) include such Target in the Research Collaboration. If the Research Management Committee or Roche Bioscience elects to exclude such Target from the Research Collaboration, then each Party may pursue HTS, development and commercialization activities against such Target outside of the Research Collaboration subject to any proprietary rights of the other Party (including its Affiliates) or any Third Party; provided, however, that the Party that did not discover such Target shall not use any information developed during the Research Collaboration with respect to such Target; and provided, further, that the Party discovering such Target may not license it to a Third Party during the Research Term and applicable Tail Period, if any. If Roche bioscience elects to include such Target in the Research Collaboration, then it shall be treated as a Shared Target (as defined below).
Sample 1Sample 2
New Targets. 2.7.1 Tularik may, in its sole discretion, (i) [ * ] New Target Candidates; (ii) [ * ] to determine whether compounds from the Tularik Compound Library agonize and/or antagonize such New Target Candidates; and/or (iii) [ * ] with respect to compounds that agonize and/or antagonize such New Target Candidates. In the event Tularik determines, in its sole discretion, to [ * ] as of the Effective Date, the opportunity: (A) to [ * ] a New Target Candidate (a "Research Opportunity"); or (B) to [ * ] a New Target Candidate (a "Compound Opportunity"); Tularik shall [ * ] in a written notice reasonably describing such [ * ], or such [ * ] shall have no obligation to offer to Xxxxx any: (Y) [ * ]; or (Z) [ * ]; in which case Tularik shall [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of this Securities Act of 1933, as amended. be obligated to offer to Xxxxx such [ * ] or such Compound Opportunity that relates to such compound that [ * ].
Sample 1Sample 2
New Targets. The targets agreed for the coming year are derived directly from the performance areas of the UFO profile and the organisational and/or departmental goals. For academic staff, agreements regarding knowledge valorisation and management tasks will also be included in the targets, in addition to agreements on education and research;
Sample 1
New Targets. If a Target is discovered as part of the Research Collaboration, the Party discovering such new Target shall notify the Research Management Committee. At the next Research Management Committee meeting, the parties shall discuss such new Target. If the Research Management Committee decides that the new Target should be included in the Research Collaboration, then Roche Bioscience shall [ * ]. If the new Target is not [ * ] at such time, such new Target shall be [ * ]. If the new Target is [ * ] at such time, Roche Bioscience shall [ * ]. If the Research Management Committee or Roche Bioscience elects to [ * ], then each Party may [ * ] of the other Party (including its Affiliates) or any Third Party; provided, however, that the Party that did not discover such Target shall not [ * ].
Sample 1
New Targets. (A) The two (2) initial New Targets in the Inflammation Therapeutic Area mutually agreed by the Parties as of the Amendment No. 2 Execution Date are [***] and [***] (each, an “Initial New Target”).
Sample 1
New Targets. (a) During the Reserved Target Exclusivity Period, Ultragenyx shall have the right to replace each Reserved Target with a proposed new Target by providing Arcturus with written notice thereof; provided that as of the time Ultragenyx provides such notification, (i) Arcturus has not already granted an option or a license to any Third Party to ***Confidential Treatment Requested
Sample 1
AutoNDA by SimpleDocs

Related to New Targets

  • Targets a) Seller’s supplier diversity spending target for Work supporting the construction of the Project prior to the Commercial Operation Date is ____ percent (___%) as measured relative to Seller’s total expenditures on construction of the Project prior to the Commercial Operation Date, and;

  • Development Milestones In addition to its obligations under Paragraph 7.1, LICENSEE specifically commits to achieving the following development milestones in its diligence activities under this AGREEMENT: (a) (b).

  • Performance Targets Threshold, target and maximum performance levels for each performance measure of the performance period are contained in Appendix B.

  • Milestones Subject to the provisions of the SGIP, the Parties shall agree on milestones for which each Party is responsible and list them in Attachment 4 of this Agreement. A Party’s obligations under this provision may be extended by agreement. If a Party anticipates that it will be unable to meet a milestone for any reason other than a Force Majeure event, it shall immediately notify the other Parties of the reason(s) for not meeting the milestone and (1) propose the earliest reasonable alternate date by which it can attain this and future milestones, and (2) requesting appropriate amendments to Attachment 4. The Party affected by the failure to meet a milestone shall not unreasonably withhold agreement to such an amendment unless it will suffer significant uncompensated economic or operational harm from the delay, (1) attainment of the same milestone has previously been delayed, or (2) it has reason to believe that the delay in meeting the milestone is intentional or unwarranted notwithstanding the circumstances explained by the Party proposing the amendment.

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Development Schedule The Project shall substantially comply with the specific timetables and triggers for action set forth in Article 5 of this Agreement. The parties acknowledge that, as provided in G.S. 160A-400.25(b), the failure to meet a commencement or completion date shall not, in and of itself, constitute a material breach of this Agreement pursuant to G.S. 160A-400.27 but must be judged based upon the totality of the circumstances.

  • Acquisition Target Not Selected Prior to the date hereof, the Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

Time is Money Join Law Insider Premium to draft better contracts faster.